Boceprevir triple therapy of chronic HCV genotype 1 (G1) infection in previously untreated patients: Efficacy, predictability of virologic response and safety in German real-life

P Buggisch; H Löhr; G Teuber; H Steffens; M Kraus; P Geyer; B Weber; T Witthöft; U Naumann; E Zehnter; D Hartmann; B Dreher; M Bilzer

doi:10.1055/s-0035-1567994

Boceprevir triple therapy of chronic HCV genotype 1 (G1) infection in previously untreated patients: Efficacy, predictability of virologic response and safety in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1567994 ◽

2015 ◽

Vol 53 (12) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv

Download Full-text

High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1386302 ◽

2014 ◽

Vol 52 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rate ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

End Of Treatment ◽

Hcv Genotype 1 ◽

Virologic Response Rate

Download Full-text

Baseline predictors of an early virologic response (EVR) in previously untreated patients undergoing boceprevir (BOC) triple therapy for HCV genotype 1 infection in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1397212 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Early Virologic Response ◽

Hcv Genotype ◽

Hcv Genotype 1

Download Full-text

Su1068 Treatment of Previously Untreated Patients With Chronic HCV Genotype 1 Infection With Boceprevir in German Real-Life: High Efficacy in Patients With Early Virologic Response

Gastroenterology ◽

10.1016/s0016-5085(14)63559-9 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-979-S-980

Author(s):

Peter Buggisch ◽

Hanns Löhr ◽

Gerlinde Teuber ◽

Hermann Steffens ◽

Michael Kraus ◽

...

Keyword(s):

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

High Efficacy ◽

Early Virologic Response ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv

Download Full-text

Boceprevir triple therapy of HCV genotype 1 (G1) infection in German real-life: comparable high SVR rates up to 87% in treatment-naïve and previously treated patients who achieve an early virologic response

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1559171 ◽

2015 ◽

Vol 53 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Early Virologic Response ◽

Hcv Genotype ◽

Treatment Naïve ◽

Previously Treated Patients ◽

Previously Treated ◽

Hcv Genotype 1

Download Full-text

Treatment of previously untreated patients with chronic HCV genotype 1 infection with Boceprevir (BOC) in German real-life: High efficacy in patients with early virologic response

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1386298 ◽

2014 ◽

Vol 52 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

High Efficacy ◽

Early Virologic Response ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv

Download Full-text

Treatment of previously untreated patients with chronic HCV genotype 1 infection with boceprevir in German real-life: high end of treatment response of 95% in patients with early virologic response

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1397256 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Treatment Response ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Early Virologic Response ◽

Hcv Genotype ◽

End Of Treatment ◽

Hcv Genotype 1 ◽

Chronic Hcv

Download Full-text

Baseline gamma-GT levels within the normal range predict high virologic response rates in treatment-naïve patients undergoing boceprevir triple therapy for HCV genotype 1 (G1) infection

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1397211 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

HF Löhr ◽

G Teuber ◽

H Steffens ◽

MR Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rates ◽

Virologic Response ◽

Genotype 1 ◽

Normal Range ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1

Download Full-text

Efficacy and safety of Boceprevir triple therapy in previously treated patients with HCV Genotype 1 (G1) infection in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1567991 ◽

2015 ◽

Vol 53 (12) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Efficacy And Safety ◽

Genotype 1 ◽

Hcv Genotype ◽

Previously Treated Patients ◽

Previously Treated ◽

Hcv Genotype 1

Download Full-text

Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis

World Journal of Hepatology ◽

10.4254/wjh.v6.i10.759 ◽

2014 ◽

Vol 6 (10) ◽

pp. 759 ◽

Cited By ~ 3

Author(s):

Nicolae-Catalin Mechie

Keyword(s):

Protease Inhibitor ◽

Triple Therapy ◽

Meta Analysis ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv

Download Full-text

912 LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE IN PATIENTS UNDERGOING PEGINTERFERON alfa-2b/RIBAVIRIN TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(13)60914-9 ◽

2013 ◽

Vol 58 ◽

pp. S376

Author(s):

G. Teuber ◽

S. Mauss ◽

D. Hüppe ◽

E. Zehnter ◽

M.P. Manns ◽

...

Keyword(s):

Sustained Virologic Response ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text